Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microtubulin binding sites as target for developing anticancer agents.

Mohd N Islam1, Magdy N Iskander

  • 1Department of Medicinal Chemistry, Victorian College of Pharmacy, Monash University, 381 Royal Parade, Parkville, 3052, Victoria, Australia.

Mini Reviews in Medicinal Chemistry
|December 8, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of the pharmacological properties of 5-methoxyindole derivatives at 5-HT4 receptors.

The Journal of pharmacy and pharmacology·2012
Same author

Synthesis, testing and structure-activity studies on a library of 5-HT₄ ligands.

Medicinal chemistry (Shariqah (United Arab Emirates))·2010
Same author

Stability studies of oxazolidine-based compounds using 1H NMR spectroscopy.

Journal of pharmaceutical sciences·2010
Same author

Synthesis and preliminary screening of novel indole-3-methanamines as 5-HT4 receptor ligands.

European journal of medicinal chemistry·2009
Same author

Macrophage migration inhibitory factor: a therapeutic target across inflammatory diseases.

Inflammation & allergy drug targets·2007
Same author

Macrocyclic diarylheptanoids from Garuga pinnata.

Phytochemistry·2006

Microtubules are vital for cell functions, and tubulin is a key target for anticancer drugs. New tubulin-binding agents are needed to overcome resistance to existing therapies.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Pharmacology

Background:

  • Microtubules (MTs) are essential for eukaryotic cell functions, including mitosis, cell motility, and intracellular transport.
  • Alpha- and beta-tubulin, the primary components of MTs, are crucial for their dynamic instability and cellular roles.
  • Tubulin is a validated target for anticancer drug development, with established agents like taxanes and vinca alkaloids.

Purpose of the Study:

  • To review structure-activity relationships (SAR) of various antimitotic agents targeting tubulin.
  • To highlight the need for novel natural analogs that interact with tubulin at distinct sites.
  • To provide essential data for scientists involved in anticancer drug design.

Main Methods:

  • Literature review of antimitotic agents and their interaction with tubulin.

Related Experiment Videos

  • Analysis of structure-activity relationships (SAR) for different classes of tubulin-binding compounds.
  • Compilation of data on natural analogs with antimitotic potential.

    • Main Results:

    • Tubulin-binding molecules, including taxanes and vinca alkaloids, are effective antimitotic agents.
    • Resistance to existing tubulin-targeting drugs necessitates the development of new agents.
    • Various natural compounds exhibit antimitotic activity by interfering with tubulin dynamics.

    Conclusions:

    • Tubulin remains a critical target for developing novel anticancer therapeutics.
    • Developing new antimitotic agents with unique binding mechanisms is essential to overcome drug resistance.
    • SAR data on diverse tubulin-binding agents are vital for future drug discovery efforts in oncology.